Binita Chakraborty
YOU?
Author Swipe
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment
Estrogens increase cancer cell efferocytosis to establish an immunosuppressive tumor microenvironment Open
Phagocytic clearance of apoptotic cancer cells (efferocytosis) by tumor-associated macrophages (TAMs) contributes in a substantial manner to the establishment of an immunosuppressive tumor microenvironment. This puts in context our observa…
View article: Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth
Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth Open
Estrogens regulate eosinophilia in asthma and other inflammatory diseases. Further, peripheral eosinophilia and tumor-associated tissue eosinophilia (TATE) predicts a better response to immune checkpoint blockade (ICB) in breast cancer. Ho…
View article: Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 3
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 3 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 3
View article: Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 4
View article: Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 1
View article: Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 4 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 4
View article: Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Data from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Triple-negative breast cancers (TNBCs) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early stage localized TNBC, the rate of distant recurrence remains high, and long-term …
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 2
View article: Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 1 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 1
View article: Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis
Supplementary Video 2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis Open
Supplementary Video 2
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 1 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 1
View article: Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 2
View article: Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 4 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 4
View article: Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Video 3 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Supplementary Video 3
View article: Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Data from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Contains Supplementary Figures 1-4, Supplementary Tables 1-2 and legends for Supplementary Videos 1-4
View article: Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis
Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis Open
Triple-negative breast cancers (TNBC) tend to become invasive and metastatic at early stages in their development. Despite some treatment successes in early-stage localized TNBC, the rate of distant recurrence remains high, and long-term s…
View article: Ca<sup>2+</sup>/Calmodulin Dependent Protein Kinase Kinase-2 (CaMKK2) promotes Protein Kinase G (PKG)-dependent actin cytoskeletal assembly to increase tumor metastasis
Ca<sup>2+</sup>/Calmodulin Dependent Protein Kinase Kinase-2 (CaMKK2) promotes Protein Kinase G (PKG)-dependent actin cytoskeletal assembly to increase tumor metastasis Open
Triple-negative breast cancers (TNBCs) tend to become highly invasive early during cancer development. Despite some successes in the initial treatment of patients diagnosed with early-stage localized TNBC, the rate of metastatic recurrence…